Skin conditions: article presents ivermectin cream as a possible treatment

The article says one in four Americans — more than 84 million — are affected by skin diseases and promotes a topical ivermectin cream that combines ivermectin, azelaic acid, and metronidazole.

An article published March 5 presents a topical ivermectin cream as a treatment option for common skin conditions. It notes that one in four Americans — more than 84 million people — are affected by dermatologic diseases and that rates have risen in recent years. The piece describes a product from The Wellness Company that combines ivermectin with azelaic acid and metronidazole. The article frames multiple past uses of ivermectin and includes endorsements and usage guidance as part of its presentation. Key points reported: - The article states that one in four Americans, more than 84 million people, are impacted by skin diseases. - It describes a topical product that combines ivermectin with azelaic acid and metronidazole and says the product is doctor-prescribed. - The article lists conditions the product is promoted for, including acne, rosacea, dermatitis, lice, and other inflammatory skin concerns. - The article includes suggested use information and names The Wellness Company and specific clinicians as proponents; these elements are described as claims within the piece. Summary: The article frames a topical ivermectin combination as a response to a high prevalence of skin disease in the United States and highlights product ingredients and intended uses. The piece presents claims about past uses and endorsements but does not report regulatory findings or independent clinical verification. Undetermined at this time.